| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/30/2011 | WO2011076687A1 Pyridinone derivatives and pharmaceutical compositions thereof |
| 06/30/2011 | US20110160232 Certain chemical entities and therapeutic uses thereof |
| 06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 06/30/2011 | US20110160168 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160161 Concentrated therapeutic phospholipid compositions |
| 06/30/2011 | US20110160135 Suppression of neuroendocrine diseases |
| 06/30/2011 | US20110160134 Device and Method for Making Solid Beads |
| 06/30/2011 | US20110160129 Therapeutic Agent Preparations for Delivery Into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device |
| 06/30/2011 | CA2784841A1 Phenol derivatives and the pharmaceutical or cosmetic use thereof |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338498A1 Compositions for the inhibition of protein kinase C alpha for the treatment of diabetes mellitus |
| 06/29/2011 | EP1907394B1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 06/29/2011 | CN102112476A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2011 | CN102112145A Suppression of neuroendocrine diseases |
| 06/29/2011 | CN102108372A Preparation method and application of beta-glucan |
| 06/29/2011 | CN102106805A Cymipristone solid preparation and preparation methods thereof |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968603 Solid forms of selective androgen receptor modulators |
| 06/28/2011 | CA2614529C Pyridazinone derivatives as thyroid hormone receptor agonists |
| 06/28/2011 | CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 06/23/2011 | WO2011075056A1 Protein composition |
| 06/23/2011 | WO2011073298A1 Tetrazole derivatives as nicotinic acetylcholine receptor modulators |
| 06/23/2011 | WO2011073297A1 Tetrazole derivatives as nicotinic acetylcholine receptor moudlators |
| 06/23/2011 | WO2011072509A1 Progesterone formulation composition and preparation method thereof |
| 06/23/2011 | WO2010144502A9 Growth hormone polypeptides and methods of making and using same |
| 06/23/2011 | US20110152351 Modulation of smrt expression |
| 06/23/2011 | US20110152329 Use of Epothilone Derivatives for the Treatment of Hyperparathyroidism |
| 06/23/2011 | US20110152288 Methods of treating vasomotor symptoms |
| 06/23/2011 | US20110152254 Sirtuin modulating compounds |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152187 Insulin-like growth factor fusion proteins |
| 06/23/2011 | US20110152174 Inhibition of secretion from non-neuronal cells |
| 06/23/2011 | US20110151480 Methods of purifying zsig33 |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151036 Aromatase activator |
| 06/23/2011 | US20110151006 Stimuli-responsive hydrogel |
| 06/23/2011 | CA2781999A1 Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2335709A1 Insulin resistance improving agent |
| 06/22/2011 | EP2334377A1 Herbal extract as sensitivity enhancer toward insulin and antidiabetes |
| 06/22/2011 | EP2026799B1 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
| 06/22/2011 | EP1328545B1 Human gene critical to fertility |
| 06/22/2011 | CN102105484A Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 06/22/2011 | CN102100891A Preparation technology and production method of new integrative formulation of true warrior decoction |
| 06/22/2011 | CN102100886A Technology and method for preparing novel combined formulation of relieving-edema decoction |
| 06/22/2011 | CN102100684A Application of secoisolariciresinol in preparation of medicament for treating depression and anxiety |
| 06/22/2011 | CN101175747B Substituted N-arylpyrrolidines as selective androgen receptor modulators |
| 06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 06/21/2011 | US7964183 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 06/21/2011 | US7963935 Microprojection array having a beneficial agent containing coating |
| 06/21/2011 | CA2396785C A medicinal aerosol formulation |
| 06/21/2011 | CA2345079C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 06/16/2011 | WO2011069799A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | WO2011069798A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | WO2011069797A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | WO2011069796A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | WO2011069795A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | WO2011069794A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | WO2011029547A8 Isoxazolidine derivatives |
| 06/16/2011 | WO2010096886A3 Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof |
| 06/16/2011 | US20110144095 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/16/2011 | US20110144083 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
| 06/16/2011 | US20110144071 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs |
| 06/16/2011 | US20110144017 Protein conjugates and methods for their preparation |
| 06/16/2011 | US20110144007 Glucose-dependent insulinotropic polypeptide analogues |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110142932 Pharmaceutical Tablets Comprising a Plurality of Segments |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142901 Sustained release composition |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | CA2783678A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783654A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783651A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783610A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783514A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783513A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/15/2011 | EP2332995A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332535A1 Solid pharmaceutical composition |
| 06/15/2011 | EP2197479B1 Inositol pyrophosphates determine exocytotic capacity |
| 06/15/2011 | EP1812404B1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 06/15/2011 | EP1751189B1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 06/15/2011 | EP1407267B1 Gel compositions |
| 06/15/2011 | CN1700923B Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 06/15/2011 | CN102099368A C-21 thioethers as glucocorticoid receptor agonists |
| 06/15/2011 | CN102099360A Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
| 06/15/2011 | CN102093460A Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin |
| 06/15/2011 | CN102093381A 6H-benzofuran[3,2-c][1]benzopryan-6-ketone compound as well as preparation method and application of 6H-benzofuran[3,2-c][1] benzopryan-6-ketone compound |
| 06/15/2011 | CN102091082A Ginsenoside Rb3 composition and application thereof in preparing medicament for treating diabetes |
| 06/15/2011 | CN102091079A Method and composition for transdermal drug delivery |
| 06/15/2011 | CN102091068A Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS) |
| 06/15/2011 | CN102091060A Drug for treating or preventing hypogonadism, sexual dysfunction and/or sterility mediated by glucocorticoid and application thereof |
| 06/15/2011 | CN102091026A Externally applied antithyroid gel and preparation method thereof |